Studies have found that up-regulation of Ets-1 expression enhances transforming growth factor β (TGF-β)-induced hepatocyte apoptosis and accelerates liver inflammation and fibrosis in nonalcoholic steatohepatitis (NASH) mice (Liu et al., 2019). This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatohepatitis.